跳至主要内容
临床试验/NCT05248932
NCT05248932已完成4 期

Role of Norepinephrine Infusion in Preventing Hypotension During Spinal Anesthesia for Cesarean Delivery.

Menoufia University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年1月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
40
试验地点
1
主要终点
throracic volume variations change from baseline

研究概览

简要总结

This study will be conducted on 40 healthy women having spinal anesthesia for elective cesarean delivery in the operating rooms at Menoufia university hospital.

详细描述

Informed written consent will be taken from all subjects included in the study after approval of the study by the local ethical committee.

All subjects will be subjected to thorough history taking with risk factors, medical histories, general clinical examination, local clinical examination, laboratory investigations as complete blood count and coagulation profile.

Standardized anesthetic care will be provided according to institutional standards, which include fasting, antacid premedication and noninvasive hemodynamic monitoring After arrival in the operating room, patients will be positioned supine with left lateral tilt, pulse oximeter, ECG leads, non-invasive blood pressure cuff and cardiometry leads (4 surface ECG electrodes is attached to the left side of the neck and the lower thorax (approximately at the level of the xiphoid process) will be attached to patient for monitoring of blood pressure (bp), heart rate, fluid responsiveness (thoracic volume variations and stroke volume variations), cardiac index and systemic vascular resistance and values will be recorded as a baseline and every 10 minutes after intrathecal injection.

10 ml/kg/hr lactated ringer solution will be infused to all patients through an 18 gauge intravenous cannula for 30 minutes as a preload before spinal anesthesia then reduced to maintenance infusion of 6 ml/kg/hr.

Patients will be then placed in sitting position. After skin disinfection and skin infiltration with lidocaine 1%, spinal anesthesia will be performed with 2ml 0.5% hyperbaric bupivacaine (10 mg) in addition to 0.5 ml fentanyl (25 μg) at L3-L4 or L4-L5.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA I & II
  • Non laboring
  • Normotensive
  • Elective cesarean delivery under spinal anesthesia.
  • Baseline systolic blood pressure 90-140 mm Hg

排除标准

  • Known fetal abnormality.
  • Preexisting or pregnancy-induced hypertension.
  • Known cardiovascular or cerebrovascular disease.
  • Thrombocytopenia, coagulopathy or any contraindication to spinal anesthesia.
  • Weight <50 or >100 kg, height <140 or >180 cm.
  • Inability or refusal to give informed consent

研究组 & 干预措施

infusion

Active Comparator

patients will receive an infusion of norepinephrine that will be started at 2.5μg/min immediately after intrathecal injection and then manually adjusted according to monitoring of blood pressure (bp), heart rate, fluid responsiveness (thoracic volume variations and stroke volume variations), cardiac index and systemic vascular resistance by using cardiometry, with the objective of maintaining values near baseline

干预措施: cardiometry (Device)

infusion

Active Comparator

patients will receive an infusion of norepinephrine that will be started at 2.5μg/min immediately after intrathecal injection and then manually adjusted according to monitoring of blood pressure (bp), heart rate, fluid responsiveness (thoracic volume variations and stroke volume variations), cardiac index and systemic vascular resistance by using cardiometry, with the objective of maintaining values near baseline

干预措施: Norepinephrine infusion (Drug)

bolus

Active Comparator

patient with no prophylactic vasopressor and a bolus of 5 μg norepinephrine will be given whenever systolic BP decreases to <80% of the baseline value.

干预措施: Norepinephrine bolus (Drug)

bolus

Active Comparator

patient with no prophylactic vasopressor and a bolus of 5 μg norepinephrine will be given whenever systolic BP decreases to <80% of the baseline value.

干预措施: cardiometry (Device)

结局指标

主要结局

throracic volume variations change from baseline

时间窗: every 10 minutes up to 1 hour

using cardiometry

cardiac index change from baseline

时间窗: every 10 minutes up to 1 hour

using cardiometry

systemic vascular resistance change from baseline

时间窗: every 10 minutes up to 1 hour

using cardiometry

stroke volume variation change from baseline

时间窗: every 10 minutes and up to 1 hour

using cardiometry

次要结局

  • umblical cord gases sample(in the first minute after delivery)
  • APGAR score(after 5 minutes and 10 minutes after delivery)
  • Non invasive MEAN blood pressure(every 10 minutes and up tp 1 hour)
  • Heart rate(every 10 minutes and up to 1 hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

mostafa saieed fahim mansour

lecturer

Menoufia University

研究点 (1)

Loading locations...

相似试验